These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1006626)

  • 1. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration.
    Andersson LO; Barrowcliffe TW; Holmer E; Johnson EA; Sims GE
    Thromb Res; 1976 Dec; 9(6):575-83. PubMed ID: 1006626
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin.
    Höök M; Björk I; Hopwood J; Lindahl U
    FEBS Lett; 1976 Jul; 66(1):90-3. PubMed ID: 1278445
    [No Abstract]   [Full Text] [Related]  

  • 3. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
    Takahashi HK; Nader HB; Dietrich CP
    Arzneimittelforschung; 1985; 35(11):1620-3. PubMed ID: 4091864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding to antithrombin of heparin fractions with different molecular weights.
    Danielsson A; Björk I
    Biochem J; 1981 Feb; 193(2):427-33. PubMed ID: 7305940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular weight dependence of the anticoagulant properties of heparin: intravenous and subcutaneous administration of fractionated heparins to man.
    Lane DA; MacGregor IR; VanRoss M; Cella G; Kakkar VV
    Thromb Res; 1979; 16(5-6):651-62. PubMed ID: 524315
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
    Horner AA
    Biochem J; 1987 Jun; 244(3):693-8. PubMed ID: 3446185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-activity heparin: chain length, affinity for antithrombin, and anticoagulant activity.
    Radoff S; Danishefsky I
    Arch Biochem Biophys; 1982 Apr; 215(1):163-70. PubMed ID: 7092223
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
    Krulder JW; Strebus AF; Meinders AE; Briët E
    Haemostasis; 1996; 26(2):85-9. PubMed ID: 9119287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin in vertebrate species: conservation of the heparin-dependent anticoagulant mechanism.
    Jordan RE
    Arch Biochem Biophys; 1983 Dec; 227(2):587-95. PubMed ID: 6607710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular-weight-dependence of the anti-coagulant activity of heparin.
    Laurent TC; Tengblad A; Thunberg L; Höök M; Lindahl U
    Biochem J; 1978 Nov; 175(2):691-701. PubMed ID: 743219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation of heparin into fractions with different anticoagulant activity by hydrophobic interaction chromatography.
    Ogamo A; Uchiyama H; Nagasawa K
    Biochim Biophys Acta; 1980 Dec; 626(2):477-85. PubMed ID: 7213665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation of heparin on Sepharose CL-4B in the presence of high concentrations of ammonium sulphate.
    Uchiyama H; Fujimoto N; Sakurai K; Nagasawa K
    J Chromatogr; 1984 Mar; 287(1):55-66. PubMed ID: 6725457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dependence of antithrombin III and thrombin binding stoichiometries and catalytic activity on the molecular weight of affinity-purified heparin.
    Nesheim M; Blackburn MN; Lawler CM; Mann KG
    J Biol Chem; 1986 Mar; 261(7):3214-21. PubMed ID: 3949769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
    J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant properties of heparin and heparin fractions.
    Holmer E
    Scand J Haematol Suppl; 1980; 36():25-39. PubMed ID: 6935760
    [No Abstract]   [Full Text] [Related]  

  • 16. [The antithrombin effect of heparin; role of heparin concentration].
    BURSTEIN M
    C R Seances Soc Biol Fil; 1952 May; 146(9-10):641-2. PubMed ID: 12998196
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of heparin cofactor II by heparin oligosaccharides.
    Maimone MM; Tollefsen DM
    Biochem Biophys Res Commun; 1988 May; 152(3):1056-61. PubMed ID: 3377765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of protamine on heparin-antithrombin III complexes. In vitro studies.
    Kitani T; Nagarajan SC; Shanberge JN
    Thromb Res; 1980 Feb 1-15; 17(3-4):367-74. PubMed ID: 7368168
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on a highly active anticoagulant fraction of high molecular weight isolated from porcine sodium heparin.
    Sache E; Maillard M; Bertrand H; Maman M; Kunz M; Choay J; Fareed J; Messmore H
    Thromb Res; 1982 Mar; 25(6):443-58. PubMed ID: 7112506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.